<DOC>
	<DOCNO>NCT01310673</DOCNO>
	<brief_summary>Medical teaching suggest allopurinol initiate set acute attack gout , rapid lower serum urate may exacerbate attack . This study test hypothesis difference patient report daily pain flair occurrence early versus delay institution allopurinol acute gout attack .</brief_summary>
	<brief_title>Initiation Allopurinol First Medical Contact Acute Attacks Gout</brief_title>
	<detailed_description>Design : Randomized , placebo-controlled , double-blind trial . Setting : Outpatient clinic , White River Junction Veterans Affairs Medical Center . Patients : 57 men crystal proven acute gout attack , first medical contact , within 7 day onset . Intervention : Subjects randomize receive allopurinol 300mg daily match placebo 10 day . All patient receive indomethacin 50mg TID 10 day , prophylactic dose colchicine 0.6mg BID 90 day , open-label allopurinol start day 11 . Measurements : Primary outcome patient report pain visual analogue scale ( VAS ) primary joint , self report flare joint day 1-30 . Secondary endpoint include urate , sedimentation rate , C-reactive protein level .</detailed_description>
	<mesh_term>Gout</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>First medical contact acute attack gout . ACR criterion acute attack gout Crystal proven arthrocentesis day enrollment Primary gout Secondary Gout Tophaceous Gout Prior steroid , colchicine , uric acid lower therapy past 6 month . Uncontrolled CHF Unstable angina Renal insufficiency ( entry CREAT &gt; 1.3 ) Anticoagulant therapy Immunosuppressive therapy chemotherapy past 6 month Pregnancy ; OR Known allergy NSAID , colchicine , allopurinol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Gout</keyword>
	<keyword>Allopurinol</keyword>
	<keyword>Acute gout</keyword>
</DOC>